TrialAmerican journal of nephrology2021

Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.

Takashi Shigematsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.